Colette Shen, MD
Enriched profileAssistant Professor, University of North Carolina · University of North Carolina at Chapel Hill
Colette Shen is Assistant Professor, University of North Carolina at University of North Carolina at Chapel Hill. OpenAlex indexes 243 publications with 3,375 citations (h-index 31); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 26 Oct 2026
Overview
Updated 27 Oct 2026
Colette Shen, MD, is Assistant Professor, University of North Carolina at University of North Carolina at Chapel Hill. The public record shows 243 publications with 3,375 citations (h-index 31), centered on Head and Neck Cancer Studies, Brain Metastases and Treatment, Glioma Diagnosis and Treatment. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 5 companies.
- Most recent indexed publication: 2026 · Neuro-oncology
- Top research focus: Head and Neck Cancer Studies
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 54.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 26 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia
Sponsor: UNC Lineberger Comprehensive Cancer Center
- SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Sponsor: Canadian Cancer Trials Group
Industry payments
Updated 26 Oct 2026
5 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- Janssen Scientific Affairs, LLCProgram year20253 payments
- Janssen Pharmaceuticals, IncProgram year20251 payment
- Novocure Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
100%Corticosteroid100%Dexamethasone100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 26 Oct 2026
66 congress contributions (2014–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- An 8-year single institution review of demographic trends and treatment patterns among patients with anaplastic thyroid carcinoma.
ASCO Annual Meeting
ASCO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 26 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Bioactive hydrogels made from step-growth derived PEG–peptide macromersArticle215 citations2010
- 04
- 05
Network
Updated 26 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 26 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/colette-shen-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
pdsoros.org
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pdsoros.org ↗ - Other
unclineberger.org/directory/colette-shen
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 26 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pdsoros.org ↗
- MD
PhD (Bioengineering), University of Pennsylvania
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pdsoros.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →unclineberger.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pdsoros.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pdsoros.org ↗
Secondary affiliations
appointments beyond the home institution- Director
UNC Cyberknife Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.unc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Douglas Drossman, MD
University of North Carolina at Chapel Hill
Michael Knowles, MD
University of North Carolina at Chapel Hill
Neal Futran, MD
University of Washington (UW Medicine)
Everett Vokes, MD
University of Chicago
Maura Gillison, MD
The University of Texas MD Anderson Cancer Center
Antonio Jimeno, MD
University of Colorado Cancer Center